Under construction – not a live service
Sign in
Taking people in PolandNo phase

Studies frailty and heart outcomes in older adults with coronary artery disease

Checks whether frailty scores predict outcomes in older adults treated for heart artery disease.

Key facts

Who runs it
Medical University of Silesia
Where
Zabrze, PolandSee the site
Trial code
Registry title
Frailty Syndrome in Daily Practice of Interventional Cardiology Ward
Status
Recruiting
People taking part
1,000 people, planned
Started
17 May 2017
Expected to end
31 Dec 2027
Type of study
Observational, 4 groups
Record updated
12 April 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 65 or older who are in hospital with symptomatic coronary artery disease. It studies how frailty affects treatment results.

Age
65 years or older
Sex
Men and women can join.
Disease stage
Symptomatic coronary artery disease: stable, unstable, NSTEMI or STEMI.

Main reasons for not taking part

  • People who have not given written, informed consent cannot join.

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • aged ≥ 65
  • symptomatic coronary artery disease A) stable B) unstable C) NSTEMI D) STEMI
  • written, informed consent

Who cannot take part

  • lack of consent

Where in Poland

  • II Dept. of Cardiology in Zabrze Medical University of SilesiaZabrze, PolandContact: Beata MatyjaszczukTaking people

About the trial

What the trial wants to find out

The impact of frailty on immediate and long term outcomes of invasive treatment of coronary artery disease is not fully characterized. The assessment of frailty may help physicians in the selection of best treatment option and in the timing and modality of the follow-up. The FRAilty syndrome in daily Practice of Interventional CArdiology ward (FRAPICA) study is designed with the aim to validate the use of the Fried frailty scale and instrumental activities of daily living scale (IADL) as prognostic tools in patients admitted to hospital for symptomatic coronary artery disease, either stable, unstable, or acute coronary syndrome (ACS).

Read full original descriptionShow less

The FRAPICA study is a single center prospective study enrolling patients aged ≥65 years. The aims are (1) to describe Fried frailty scale and IADL scale distribution before hospital discharge and (2) to investigate the prognostic role of Fried frailty and IADL scores. The outcomes are: (1) results of invasive treatment, (2) its complications (periinterventional MI, contrast-induced nephropathy, blood loss), (3) three-year all-cause mortality, cardiovascular mortality, stroke, myocardial infarction, reintervention, heart failure, hospital readmission for any cause, and a composite of the above mentioned. Ancillary analyses will be focused on different clinical presentations, different tools to assess frailty and risk stratification.

The FRAPICA program will fill critical gaps in the understanding of the relation between frailty, cardiovascular disease, interventional procedures and outcome. It will enable more personalized risk assessment and identification of new targets for interventions.

The 4 groups in the trial

  • Stable coronary artery disease

    Patients with stable effort angina wil be enrolled. Based on coronary angiography, heart team will decide on medical, percutaneous angioplasty, or bypass grafting.

  • Unstable coronary artery disease

    Patients with unstable angina wil be enrolled. Based on coronary angiography, heart team will decide on medical, percutaneous angioplasty, or bypass grafting.

  • Non-ST elevation myocardial infarction

    Patients with non-ST elevation myocardial infarction wil be enrolled. Based on coronary angiography, heart team will decide on medical, percutaneous angioplasty, or bypass grafting.

  • ST-elevation myocardial infarction

    Patients with ST elevation myocardial infarction wil be enrolled. In majority of patients primary percutaneous coronary intervention will be performed. Based on coronary angiography, heart team will decide on further medical treatment, percutaneous angioplasty, or bypass grafting.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Frailty Syndrome in Daily Practice of Interventional Cardiology Ward
Plain-language title
Studies frailty and heart outcomes in older adults with coronary artery diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
12 April 2023